Q2 2026 Apollo Hospitals Enterprise Ltd Earnings Call Transcript

Nov 6, 2025 / 04:50 AM GMT

Release Date Price: ₹7638.2 (-1.88%)

Transcript

Key Points

Positve

Apollo Hospitals Enterprise Ltd (BOM:508869) reported a consolidated revenue growth of 13% year-on-year, reaching 6,304 crores.
The company's healthcare services division achieved a 9% year-on-year revenue growth, driven by insurance and cash patients.
Surgical volumes increased by 3%, with a focus on key specialties such as cardiac, oncology, neurosciences, gastroenterology, and orthopedics.
Apollo Healthco reported a 17% year-on-year revenue growth, with its digital platform, Apollo 24/7, adding 3 million new users.
The company is expanding its network with new hospitals in key metros, including Kolkata, Hyderabad, Bangalore, and Gurugram, expected to be operational in the next 12 months.

Negative

The reduction in the number of patients from Bangladesh impacted healthcare services revenue by 1% in FY26.
Medical admissions were lower in Q2 FY26 compared to the previous year, affecting overall growth.
The company anticipates EBITDA losses of around 150 crores from new hospitals in the next fiscal year.
There was a decline in inpatient volumes in the Karnataka region due to a drop in medical admissions.
The digital vertical of Apollo Healthco reported losses of 71 crores, although reduced from 101 crores in the same quarter last year.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

APLH.NS - Apollo Hospitals Enterprise Ltd
Q2 2026 Apollo Hospitals Enterprise Ltd Earnings Call
Nov 07, 2025 / 04:50AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to Apollo Hospital Limited earnings conference call.

As a reminder, all participant lines will be in the lesson mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing 0 on your touchstone phone.

Please note that this conference is being recorded.

I now hand the conference over to Mr. Dev Rishi Singh from CDR India.

Thank you and over to you, sir.

Thank you Yusuf. Good morning everyone and thank you for joining us on this call hosted by Apollo Hospital to discuss the financial

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.